COGNITION THERAPEUTICS INC. - COMMON STOCK
0,4350
04-октября-24 14:59:44
15 мин. задержка
Акции
9.9999999999989E-05
+0,02%
Сегодняшний диапазон
0,4300 - 0,4489
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Cognition Therapeutics Will Participate in the Roth Healthcare Opportunities Conference
02 окт 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
01 окт 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
Cognition Therapeutics to Participate in Upcoming September 2024 Investor Conferences
03 сен 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
22 авг 2024 06:31:24 Источник Nasdaq GlobeNewswire
-
08 авг 2024 06:00:53 Источник Nasdaq GlobeNewswire
-
Cognition Therapeutics to Report Second Quarter 2024 Financial Results
05 авг 2024 06:30:19 Источник Nasdaq GlobeNewswire
-
29 июл 2024 06:00:33 Источник Nasdaq GlobeNewswire
-
26 июл 2024 15:11:52 Источник Nasdaq GlobeNewswire
-
02 июл 2024 06:30:38 Источник Nasdaq GlobeNewswire
-
21 май 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
07 май 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
29 апр 2024 06:30:57 Источник Nasdaq GlobeNewswire
-
22 апр 2024 06:30:22 Источник Nasdaq GlobeNewswire
-
Cognition Therapeutics to Present at the Needham Virtual Healthcare Conference
02 апр 2024 06:30:47 Источник Nasdaq GlobeNewswire
-
01 апр 2024 06:30:39 Источник Nasdaq GlobeNewswire
-
Cognition Therapeutics Reports Year End 2023 Financial Results and Provides Business Update
26 мар 2024 06:00:56 Источник Nasdaq GlobeNewswire
-
Cognition Therapeutics to Report Fourth Quarter and Full Year 2023 Results
15 мар 2024 06:30:59 Источник Nasdaq GlobeNewswire
-
Cognition Therapeutics Announces Closing of $11.5 Million Public Offering of Common Stock
14 мар 2024 15:05:15 Источник Nasdaq GlobeNewswire
-
Cognition Therapeutics Announces Pricing of $11.5 Million Public Offering of Common Stock
11 мар 2024 19:16:05 Источник Nasdaq GlobeNewswire
-
Cognition Therapeutics Announces Proposed Public Offering of Common Stock
11 мар 2024 15:05:16 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >